OPPM
UTHR icon

Opus Point Partners Management’s United Therapeutics UTHR Stock Holding History

Opus Point Partners Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$279K Buy
+3,498
New +$282K 0.5% 44
2019
Q2 		– Sell
-2,199
Closed -$258K – 72
2019
Q1 		$258K Sell
2,199
-465
-17% -$54.2K 0.35% 67
2018
Q4 		$290K Sell
2,664
-141
-5% -$16.3K 0.64% 28
2018
Q3 		$359K Buy
2,805
+145
+5% +$17.9K 0.86% 39
2018
Q2 		$301K Buy
2,660
+81
+3% +$8.9K 0.65% 37
2018
Q1 		$290K Buy
2,579
+529
+26% +$67.2K 0.57% 36
2017
Q4 		$303K Sell
2,050
-2,058
-50% -$262K 0.26% 48
2017
Q3 		$481K Buy
+4,108
New +$525K 0.43% 52
2017
Q2 		– Sell
-2,756
Closed -$373K – 70
2017
Q1 		$373K Buy
2,756
+805
+41% +$122K 0.28% 60
2016
Q4 		$280K Buy
1,951
+183
+10% +$23.4K 0.22% 42
2016
Q3 		$209K Sell
1,768
-296
-14% -$35.6K 0.12% 43
2016
Q2 		$219K Sell
2,064
-1,784
-46% -$199K 0.21% 38
2016
Q1 		$429K Sell
3,848
-2,666
-41% -$337K 0.33% 48
2015
Q4 		$1.02M Buy
6,514
+943
+17% +$137K 0.67% 41
2015
Q3 		$731K Buy
5,571
+172
+3% +$27.6K 0.4% 37
2015
Q2 		$939K Buy
5,399
+186
+4% +$33.5K 0.74% 33
2015
Q1 		$899K Sell
5,213
-13,841
-73% -$2.11M 0.75% 35
2014
Q4 		$2.47M Buy
+19,054
New +$2.46M 2.44% 22

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opus Point Partners Management's UTHR Position: Q3 2019 in Review

Opus Point Partners Management opened a new position in United Therapeutics (UTHR) in Q3 2019: 3,498 shares worth $279K. The stake represents 0.5% of the portfolio and ranks #44 among its holdings. This is a return to the name: Opus Point Partners Management previously reported a position in UTHR as recently as Q1 2019.

Opus Point Partners Management first reported a position in UTHR in Q4 2014 and has held it in 18 quarters since. The position peaked at $2.47M in Q4 2014. 302 funds tracked by Wall St. Rank hold UTHR as of Q3 2019.

  • Opus Point Partners Management held 3,498 shares of United Therapeutics worth $279K as of Q3 2019.
  • United Therapeutics was a new Opus Point Partners Management position in Q3 2019.
  • United Therapeutics made up 0.5% of Opus Point Partners Management's portfolio in Q3 2019, its #44 holding.
  • Opus Point Partners Management first reported a position in United Therapeutics in Q4 2014 and has held it in 18 quarters since.
  • Opus Point Partners Management's United Therapeutics position peaked at $2.47M in Q4 2014.
  • 302 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.